Biomapas Safety Monitoring In Early Phase Oncology Trials CJC 1295 (No DAC) + Ipamorelin Synergistic GH Releasing Peptide Duo The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Patient Safety in Clinical Trials Ipamorelin Injection Suppliers, Manufacturers, Factory Wholesale Price Bloom Tech Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin